	Systemic Glucocorticoid Immunosuppression and Survival Among Immune Checkpoint Inhibitor Recipients. JAMA Netw Open Wan G, Nguyen N, Lu C, Khattab S, Yan B, Amadife M, Leung BW, Chen W, Rajeh A, Tang K, Thang C, Boland G, Reynolds KL, Yu KH, Gusev A, LeBoeuf NR, Kwatra SG, Semenov YR. PMID: 42172027 [PubMed - indexed for MEDLINE]
	Environmental Nonessential Element Exposure and Urologic Cancer: A Systematic Review and Meta-Analysis. JAMA Netw Open Deng Z, Li J, Ji R, Delgado JR, Yim SHL, Kachuri L, Cardenas A, Graff RE, Leppert JT, Dennis LK, Chung BI, Langston ME. PMID: 42172026 [PubMed - indexed for MEDLINE]
	Pandemic-Related Disruptions and Hepatocellular Carcinoma Surveillance in Safety-Net Settings. JAMA Netw Open Wong RJ, Jones P, Niu B, Pinheiro P, Thamer M, Kshirsagar O, Zhang Y, Fass R, Prieto-Bello D, Quirk L, Therapondos G, Singal AG, Khalili M. PMID: 42172025 [PubMed - indexed for MEDLINE]
	CLID: A contrastive learning approach for multi-class classification of breast cancer histopathological images with imbalanced distribution. J Xray Sci Technol Li W, Shi L, He H. PMID: 42171998 [PubMed - as supplied by publisher]
	Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities. Oncol Ther Javidan M, Jafari Z, Abbasiniya S, Jamalzehi S, Shafiei A, Khodadadi A. PMID: 42171986 [PubMed - as supplied by publisher]
	Immune-checkpoint inhibitors for advanced hepatocellular carcinoma in Child-Turcotte-Pugh-B cirrhosis: a liver-centric approach to outcomes beyond tumor progression. Hepatol Int Agrawal D, Jothimani D, Bhoori S, Reddy GN, Saigal S, Rela M, Mazzaferro V. PMID: 42171974 [PubMed - as supplied by publisher]
	Intratumoral microbiota in cancer: molecular mechanism and therapeutic strategies. Mol Biomed Yu Y, Guo Z, Luo Z, Dian Y, Yang X, Chen X, Zeng F, Deng G. PMID: 42171956 [PubMed - indexed for MEDLINE]
	Total Neoadjuvant Therapy Versus Neoadjuvant Chemotherapy Alone for High-Risk Locally Advanced Rectal Cancer: a Propensity Score Matched Study. J Gastrointest Cancer Xiong C, Yang Q, Wang W, Cha X, Li X, Li J, Tang S, Yu K. PMID: 42171940 [PubMed - indexed for MEDLINE]
	ADAM9: an updated view of its biology and pathology. Mol Biol Rep Sheela A, Mahin A, Subair S, Suresh M, Krishna R, Raju R, Soman S. PMID: 42171934 [PubMed - indexed for MEDLINE]
	Harnessing the gut microbiota to enhance immune checkpoint inhibitor efficacy: from mechanistic insights to clinical translation. Mol Biol Rep Bi Q, Zhang L, Wan H, Zhang J. PMID: 42171928 [PubMed - indexed for MEDLINE]
	Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma. Curr Oncol Rep Wysocki PT, Chmiel P, Jassem J, Kraj L. PMID: 42171914 [PubMed - indexed for MEDLINE]
	Deubiquitinases at the crossroads of ferroptosis and cancer therapy: mechanisms and therapeutic potential. Mol Biol Rep El-Sehrawy AAMA, Mohammed SN, Abdulhadi HL, Vora MA, Basunduwah TS, Singh G, Arora V, Nayak PP, Iqbal MS, Muslem WT. PMID: 42171907 [PubMed - indexed for MEDLINE]
	Genotypic and phenotypic characteristics of germline TP53 variant carriers: experience from two cancer genetic counseling units. Fam Cancer Mirete BG, Arias AF, Payá PR, Revert MV, Garcia DS, Marín MM, Benítez-Fuentes JD, González IC, Heras ABS. PMID: 42171906 [PubMed - indexed for MEDLINE]
	Real-time virtual sonography for prone-position breast MRI: technical feasibility and accuracy in locating 125 breast lesions. Eur Radiol Exp Gruber L, Swoboda M, Deeg J, Amort B, Haushammer S, Egle D, Iannetti C, Ladenhauf VK, Galijasevic M, Lacaita P, Daniaux M, Henninger B, Gizewski ER. PMID: 42171883 [PubMed - indexed for MEDLINE]
	TFPI2 expression predicts resistance to immunotherapy plus tyrosine kinase inhibitor and informs first-line therapy selection in metastatic renal cell carcinoma. Cell Oncol (Dordr) Wang J, Du L, Wang Y, Wang H, Zhu Y, Xu X. PMID: 42171882 [PubMed - as supplied by publisher]
	A phase 1 study of PF-07260437, a B7-H4â€‰Ã—â€‰CD3 bispecific T-cell engager, in patients with advanced or metastatic breast, ovarian, and endometrial cancer. Invest New Drugs Yan F, Cruz-Correa M, Specht J, Wang EW, Lu J, Soliman H, Jackson-Fisher A, Tang SY, Jiang S, Le Corre C, Li M, Sommerhalder D. PMID: 42171881 [PubMed - as supplied by publisher]
	Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion. J Hematop Cook JR, Astbury C, Bosler DS, Molina JC, Rogers HJ, Sobecks RM, Owczarczyk AB. PMID: 42171857 [PubMed - indexed for MEDLINE]
	Post-neoadjuvant Metabolic Response Assessed by Â¹â¸F-FDG PET/CT Predicts Pathologic Complete Response and Survival in Esophageal Squamous Cell Carcinoma Treated with the CROSS Regimen. J Gastrointest Cancer Moorthy S, Arvind K, Surianarayanan P, P N, V M. PMID: 42171848 [PubMed - indexed for MEDLINE]
	Microbiome in Gastrointestinal Tumors: Implications in Oncogenesis and Therapeutic Response : Microbiome in Gastrointestinal Tumors. Curr Oncol Rep Gómez-Montañez E, Rojas-Salazar YL, Rojas-Salazar JG. PMID: 42171841 [PubMed - indexed for MEDLINE]
	Recruitment strategies for a multisite telehealth trial for rural cancer survivors with ostomies. Support Care Cancer Krouse RS, Wheeler SB, Appel S, Sun V, Nielsen ME, Hoffman RL, Garg T, Popek SM, Sticca RP, Aka AA, McFadden CL, Hesham WM, Grant M, Holcomb M. PMID: 42171813 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 1937142

Page 1 of 96858



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy